"For information about COVID-19, please visit our website."

During the past decade, Central Vermont Medical Center/National Life Cancer Treatment conducted 72 clinical trials. In the 10-year time frame, 72 clinical trials started and 56 clinical trials were completed, i.e. on average, 77.8% percent of trials that started reached the finish line to date. In the past 5 years, 20 clinical trials started and 32 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Central Vermont Medical Center/National Life Cancer Treatment" #1 sponsor was "National Cancer Institute (NCI)" with 61 trials, followed by "SWOG Cancer Research Network" with 21 trials sponsored, "Alliance for Clinical Trials in Oncology" with 17 trials sponsored, "NRG Oncology" with 9 trials sponsored and "ECOG-ACRIN Cancer Research Group" with 9 trials sponsored. Other sponsors include 1 different institutions and companies that sponsored additional 10 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Central Vermont Medical Center/National Life Cancer Treatment" #1 collaborator was "National Cancer Institute (NCI)" with 57 trials as a collaborator, "NRG Oncology" with 12 trials as a collaborator, "Canadian Cancer Trials Group" with 7 trials as a collaborator, "SWOG Cancer Research Network" with 6 trials as a collaborator and "NCIC Clinical Trials Group" with 5 trials as a collaborator. Other collaborators include 20 different institutions and companies that were collaborators in the rest 20 trials.

According to Clinical.Site data, the most researched conditions in "Central Vermont Medical Center/National Life Cancer Treatment" are "Recurrent Squamous Cell Lung Carcinoma" (9 trials), "Stage IV Squamous Cell Lung Carcinoma AJCC v7" (8 trials), "Recurrent Breast Carcinoma" (6 trials), "Stage IIIA Breast Cancer" (5 trials) and "Acute Myeloid Leukemia" (4 trials). Many other conditions were trialed in "Central Vermont Medical Center/National Life Cancer Treatment" in a lesser frequency.

Most popular intervention types in "Central Vermont Medical Center/National Life Cancer Treatment" are "Drug" (96 trials), "Other" (80 trials), "Biological" (46 trials), "Procedure" (34 trials) and "Radiation" (26 trials). Other intervention types were less common.

The name of intervention was led by "Laboratory Biomarker Analysis" (52 trials), "Quality-of-Life Assessment" (32 trials), "Questionnaire Administration" (20 trials), "Carboplatin" (13 trials) and "Nivolumab" (13 trials). Other intervention names were less common.

The vast majority of trials in "Central Vermont Medical Center/National Life Cancer Treatment" are 100 trials for "All" genders, 13 trials for "Female" genders and 6 trials for "Male" genders.

Currently, there are NaN active trials in "Central Vermont Medical Center/National Life Cancer Treatment". undefined are not yet recruiting, 24 are recruiting, 52 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 33 completed trials in Central Vermont Medical Center/National Life Cancer Treatment, 2 suspended trials, and 8 terminated clinical trials to date.

Out of the total trials that were conducted in Central Vermont Medical Center/National Life Cancer Treatment, 3 "Phase 1" clinical trials were conducted, 57 "Phase 2" clinical trials and 74 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 1 trials that are defined as “Not Applicable".